ESG News For Atricure Inc

Recap of CSR stories on Business Wire

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the company has published its 2023 Environmental, Social and Governance (ESG) Report highlighting the company’s corporate responsibility and sustainability initiatives. “At AtriCure, our focus on making a positive difference for patients is at the heart of our ESG strategy,” said Mic

Recap of CSR stories on Business Wire

Recognizes Exemplary Board Practices Related to DE&I

Recap of CSR stories on Business Wire

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today published its inaugural Environmental, Social and Governance (ESG) report highlighting the company’s corporate responsibility and sustainability initiatives. AtriCure’s 2021 ESG Report showcases several of the company’s recent ESG accomplishments, including: Achieving gender parity on the Board of